Oak Street Health shares jump more than 35% on report that CVS is nearing acquisition

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Oak Street Health Inc. shares jumped more than 35% in late trading Monday, after a report that CVS Health Corp. was nearing a $10.5 billion acquisition of...

Oak Street Health Inc. OSHshares jumped more than 35% in late trading Monday, after a report that CVS Health Corp. CVSwas nearing a $10.5 billion acquisition of the healthcare chain. The Wall Street Journal reported late Monday that the two parties were near a deal at roughly $39 a share, and it could be reported as early as this week; CVS is due to report earnings Wednesday morning. Previous reports said that the two companies were in talks for a deal of more than $10 billion.

Oak Street Health Inc. OSH shares jumped more than 35% in late trading Monday, after a report that CVS Health Corp. CVS was nearing a $10.5 billion acquisition of the healthcare chain. The Wall Street Journal reported late Monday that the two parties were near a deal at roughly $39 a share, and it could be reported as early as this week; CVS is due to report earnings Wednesday morning. Previous reports said that the two companies were in talks for a deal of more than $10 billion.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | CVS Nearing $10.5 Billion Deal for Primary-Care Provider Oak Street HealthCVS is nearing a $10.5 billion deal to acquire primary-care provider Oak Street Health, people familiar with the matter say Conflict of interest IMHO. They are the high cost pharmacy and should be rejected. IMHO.
Source: WSJ - 🏆 98. / 63 Read more »